Results 91 to 100 of about 8,781 (227)

X-linked agammaglobulinemia: clinical and immunologic evaluation of six patients

open access: yesThe Turkish Journal of Pediatrics, 1990
The clinical and immunologic features of six patients with X-linked agammaglobulinemia (XLA) are presented. The most common presenting manifestations were respiratory and gastrointestinal tract infections.
F Ersoy, O Sanal, I Tezcan, A I Berkel
doaj  

Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia

open access: yesCase Reports in Pediatrics, 2013
X-linked agammaglobulinemia (XLA) is a primary immunodeficiency of the humoral compartment, due to a mutation in the Bruton tyrosine kinase (BTK) gene, characterized by a severe defect of circulating B cells and serum immunoglobulins.
Paola Ariganello   +11 more
doaj   +1 more source

X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective [PDF]

open access: yes, 2018
X-linked lymphoproliferative disease (XLP) was first described in the 1970s as a fatal lymphoproliferative syndrome associated with infection with Epstein–Barr virus (EBV).
Baldanzi   +105 more
core   +1 more source

X-linked Agammaglobulinemia - Is it Really Rare?

open access: yesClinical Pediatrics: Open Access, 2018
Background: X-Linked Agammaglobulinemia is a disease of the immune system in which there is defective development of the B lymphocytes due to which the production of gammaglobulins is markedly reduced; which results in immunodeficiency and high vulnerability to contract fatal infections.
Hui-Ma   +5 more
openaire   +2 more sources

Valutazione della funzionalita' linfocitaria in soggetti con Immunodeficienza Comune Variabile [PDF]

open access: yes, 2015
Con il termine Sindrome da Immunodeficienza (ID) si intende un insieme di segni e sintomi dovuti a un deficit del funzionamento del sistema immunitario che si traduce in una aumentata suscettibilità alle infezioni in termini di frequenza, durata e ...
SUTERA, DONATELLA
core  

Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib [PDF]

open access: yes, 2017
The Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib induces platelet dysfunction and causes increased risk of bleeding. Off-target inhibition of Tec is believed to contribute to platelet dysfunction and other side-effects of ibrutinib.
Appleby, Niamh   +10 more
core   +2 more sources

Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease. [PDF]

open access: green, 1994
Mauno Vihinen   +9 more
openalex   +1 more source

DEVELOPMENT OF REAL-TIME MULTIPLEX PCR FOR THE QUANTITATIVE DETERMINATION OF TREC'S AND KREC'S IN WHOLE BLOOD AND IN DRIED BLOOD SPOTS

open access: yesМедицинская иммунология, 2015
Primary immunodeficiencies (PID) such as severe combined immunodeficiency (SCID) and X-linked agammaglobulinemia are characterized by the lack of functional Tand B-cells, respectively. Without early diagnosis and prompt treatment children with PID suffer
M. A. Gordukova   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy